Masterbrand (MBC) Market Summary

  • Closing Price (24‑hour period ending 20 Oct 2026, 21:03 CE): USD 6.79
  • Price Change: Down 4.88 %
  • Shares Outstanding: 203.5 million
  • Market Capitalisation: USD 1.3 billion
  • Volume Traded (last 24 h): USD 12.4 million
  • Year‑to‑Date Performance: Down 5.72 % since the previous month‑end
  • 200‑Day Simple Moving Average: USD 9.08
  • 52‑Week High: USD 13.96 (10 Feb 2026)
  • 52‑Week Low: USD 6.17 (14 Oct 2026)

SymbolCompanyPrice% ChangeMarket CapP/E Ratio
ATEXAnterixUSD 78.89–3.24 %USD 1.6 bn23.56
ICFIIcfUSD 89.53–1.08 %USD 1.6 bn18.39
AMNAmn Healthcare ServicesUSD 41.21+0.02 %USD 1.6 bn15.01
THRMGenthermUSD 29.42–1.48 %USD 1.6 bn33.93
ALNTAllientUSD 92.87+1.12 %USD 1.6 bn54.96

Key Developments

  • Anterix (ATEX): Shares fell slightly in late‑morning trading. The company disclosed a GF score of 70, a proprietary market‑sentiment metric. The decline coincided with broader market volatility; analysts are monitoring upcoming earnings for further insight.

  • Amn Healthcare Services (AMN): Released its 2026 Review of Physician and Advanced Practitioner Recruiting Incentives. The report indicates gastroenterology now leads the highest‑paid specialties, overtaking orthopedic surgery. Signing bonuses for procedural specialists have increased, and telehealth integration is expanding.

  • Allient (ALNT): Announced that Robert B. Engel, an independent director on its audit committee, will join the board of Suja Life Inc., a company specializing in organic beverages. The appointment is intended to strengthen Suja Life’s financial and risk oversight.


Company Profile – Masterbrand (MBC)

  • Industry: Industrials – Wood Kitchen Cabinets
  • Headquarters: Jasper, United States
  • Business Focus: Production of pre‑made and special‑ordered cabinetry for residential cabinet businesses across North America.

Summary

Masterbrand’s share price declined by nearly 5 % in the most recent 24‑hour period, reflecting a broader downward trend since the prior month‑end. The company’s market capitalisation remains at USD 1.3 billion, with a 200‑day moving average well above the current trading price. Related stocks in the sector exhibited mixed performance, with Anterix and Gentherm experiencing modest declines, while Amn Healthcare Services and Allient saw slight gains. Recent corporate announcements, particularly from Amn Healthcare Services and Allient, provide context for investor sentiment and potential future movements.